accountA U.S. judge ruled that the Sandoz unit of Switzerland’s second-biggest drugmaker can resume sales of King Pharmaceuticals Inc.’s Skelaxin muscle relaxant, which were temporarily halted April 1. The shares rose 9 centimes, or 1.6 percent, to 56.85...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Atos, BASF, Debenhams, France Telecom: Europe Equity Preview
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account